Live Breaking News & Updates on Dawn Hocevar

Stay updated with breaking news from Dawn hocevar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

New BioCT leader Gillon says boosting venture funding, bioscience talent pipeline key priorities

New BioCT leader Gillon says boosting venture funding, bioscience talent pipeline key priorities
hartfordbusiness.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hartfordbusiness.com Daily Mail and Mail on Sunday newspapers.

United States , New Haven , New York , Jodie Gillon , Us Congress , Connecticut Bioscience Growth Council , Johnb Pierce Laboratory , Achillion Pharmaceuticals , Alexion Pharmaceuticals , Connecticut Business Industry Association , New York City , Dawn Hocevar , Abeona Therapeutics , Connecticut Business ,

Stamford-based Cara Therapeutics gains FDA approval for itching treatment: 'A very important drug'

Stamford-based Cara Therapeutics gains FDA approval for itching treatment: 'A very important drug'
middletownpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from middletownpress.com Daily Mail and Mail on Sunday newspapers.

United States , Vifor Pharma , Abbas Hussain , Derek Chalmers , American Academy Of Dermatology Association , Us Centers For Medicare , Drug Enforcement Administration , Medicaid Services , Vifor Fresenius Medical Care Renal Pharma Ltd , Fresenius Medical Care , President Derek Chalmers , American Academy , Drug Enforcement , Switzerland Headquartered Vifor Pharma , Dawn Hocevar ,

Founder of Stamford-based Loxo Oncology launches another biotech firm


Founder of Stamford-based Loxo Oncology launches another biotech firm
FacebookTwitterEmail
Dr. Joshua Bilenker, founder and then-CEO of Loxo Oncology, makes a point during an interview at the company’s main offices on Tresser Boulevard in downtown Stamford, Conn., on July 18, 2017.Michael Cummo / Hearst Connecticut Media
STAMFORD Dr. Josh Bilenker, the founder and former CEO of Stamford-based Loxo Oncology, one of the most influential cancer-focused startups of recent years, has launched another locally based oncology firm.
Treeline Biosciences aims to “prioritize molecular targets in oncology that are validated but difficult to drug” and “if successful, we believe that our approaches could apply to other therapeutic areas as well,” Bilenker and Treeline’s other founder, Dr. Jeff Engelman, wrote in a message posted on the firm’s website. ....

United States , San Diego , Rihanna Plaza , Jacob Van Naarden , Van Naarden , Josh Bilenker , Christian Abraham Hearst , Enrique Plaza , Michael Cummo Hearst , Jake Van Naarden , Joshua Bilenker , Exchange Commission , Ajax Health Zeus , Novartis Institutes For Biomedical Research , Access Industries , T Rowe Price Associates , Eli Lilly Co , Novartis Institutes , Casdin Capital , Price Associates , Chief Business Officer Jacob Van Naarden , Tresser Boulevard , Eli Lilly , Loxo Oncology , Michael Cummo , Hearst Connecticut ,